Answers are grounded in this paper and cite their sources.
Analysis of 32 failed drug trials in autoimmune bullous diseases reveals key challenges, indicating the need for improved recruitment and endpoint strategies.
This study analysed 32 failed drug development trials and surveyed 56 experts in the field of autoimmune bullous diseases to identify key challenges in bullous pemphigoid and pemphigus research. Clinical trials primarily failed due to unmet efficacy endpoints and recruitment difficulties, with experts highlighting the need to improve endpoint selection and patient enrolment strategies through international collaboration to develop more effective trial designs and advance new therapeutic options.
No takes yet. Share an insight, caveat, or question.
Korte et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: